Position in PFE
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$13,268,333
+$1,559,233 QoQ
Shares Held
472,519
+0.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Steward Partners Investment Advisory, LLC holds $457,189,468 across 19 Drug Manufacturers - General names. PFE ranks #7 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
629,201 | $153,801,892 | |
| 2 | ABBV |
AbbVie Inc.
|
436,916 | $95,024,860 | |
| 3 | LLY |
ELI LILLY & Co
|
91,946 | $84,569,172 | |
| 4 | MRK |
Merck & Co., Inc.
|
305,398 | $36,736,325 | |
| 5 | AMGN |
Amgen Inc
|
76,905 | $27,059,024 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
244,135 | $14,806,787 | |
| 7 | PFE |
Pfizer Inc
This page
|
472,519 | $13,268,333 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
75,160 | $10,475,049 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,268,333 | 472,519 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $11,709,100 | 470,245 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $9,663,646 | 379,264 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $8,940,705 | 368,841 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $8,597,709 | 339,294 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $9,196,146 | 346,632 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $11,034,474 | 381,288 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,398,403 | 371,637 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $10,586,181 | 381,484 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $10,038,065 | 348,665 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $16,179,629 | 487,779 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $17,607,940 | 480,042 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $19,539,528 | 478,910 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $23,922,623 | 466,874 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $21,562,346 | 492,741 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $25,805,102 | 492,182 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $25,494,964 | 492,466 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $28,790,477 | 487,561 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $20,694,003 | 481,144 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $18,138,872 | 463,199 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $19,130,381 | 528,026 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $16,708,353 | 453,908 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $15,354,971 | 418,392 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $11,615,934 | 355,227 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $12,986,100 | 397,859 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||